Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App
Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...
Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...
The Post got a front-row seat, scouring thousands of booths at the Consumer Electronics Show (CES) to find the most ...
Clinical trials underrepresent women, children, and adults aged 65 years or older, so diabetes guidelines must be adapted to ...
Scientists have presented a new approach to cancer treatment using mast cells, which are immune cells known for their ability ...
Dr. Nassir Marrouche is director of the Heart and Vascular Institute at Tulane University with a subspecialty in ...
The use of AI at the doctor's office raises urgent questions about risk, equity, and informed consent for Black patients. Here's what you deserve to know.
The integration of PD-1 inhibitors into standard chemotherapy and radiotherapy regimens has revolutionized nasopharyngeal ...
Artificial intelligence is moving from our screens to our skincare. Discover how AI beauty trends are redefining personalised ...
The clinic will use artificial intelligence and genetic screening to detect and treat serious diseases such as cancer and ...
Cyclerion Strengthens Development of Closed-Loop Anesthetic Platform through Strategic Collaboration Agreement with Medsteer ...
News Medical on MSN
Method developed to identify best treatment combinations for glioblastoma based on unique cellular targets
Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating glioblastoma, a lethal brain tumor. This approach enabled them to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results